$0.802
-0.012 (-1.47%)收盘时
DH 资讯
DH 事件
Consensus 18c Narrows FY26 Revenue Outlook to $220M
Consensus 18c. Narrows FY26 revenue view to $220M from $220M-$226M, consensus $223.45M. Sees FY26 adjusted EBITDA view $57M-$59M.
Definitive Healthcare Q2 Revenue at $55.2M
Reports Q2 revenue $55.2M, consensus $55.39M. "Definitive Healthcare delivered another quarter in line with or above our guidance ranges, reflecting continued discipline alongside targeted investment in our growth priorities," said Kevin Coop, CEO of Definitive Healthcare. "We're encouraged by our second consecutive quarter of year-over-year improvement in net dollar retention, strong win-back momentum across our end markets, and the launch of Turbo, our new AI-powered healthcare intelligence platform, which marks a significant milestone in our innovation strategy. We remain confident that our focus on data quality and customer success is the right path to return to sustained, predictable growth, while continuing to generate strong profitability and cash flow."
Sees Q3 Revenue of $54M-$55M
Sees Q3 revenue $54M-$55M, consensus $55.38M. Sees Q3 adjusted EBITDA $13.5M-$14.5M.
Company Confirms FY26 Revenue Outlook of $220M to $226M
Consensus 17c. Backs FY26 revenue view $220M-$226M, consensus $223.64M. Backs FY26 adjusted EBITDA view $13.5M-$14.5M.
Sees Q2 Revenue of $55M-$56M
Sees Q2 revenue $55M-$56M, consensus $55.47M.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。